Investment Stage

Focus Areas

About Investor

Chong Xu is a Partner at F-Prime Capital Partners with a strong focus on biotechnology investing. Based in Massachusetts, he supports biotech companies across Seed, Series A, and Series B financing rounds. His investment interests include innovative therapeutics, drug discovery platforms, and life science technologies with significant commercial potential. Chong works closely with scientific founders to help accelerate development and create long-term value. F-Prime’s investment range for opportunities he supports spans from $100,000 to $10 million, with an average investment size around $5 million. Biotech startups pursuing novel scientific approaches and breakthrough healthcare solutions are likely to attract his attention.